SequelSEC

ULTRALIFE CORP ULBI

Miscellaneous Electrical Machinery, Equipment & Supplies · CIK 0000875657 · Fiscal year ends 1231

Revenue
$191.16M
Fiscal year ended 2025-12-31
Operating income
-$5.90M
Fiscal year ended 2025-12-31
Free cash flow
$7.12M
Fiscal year ended 2025-12-31

ULTRALIFE CORP (ULBI) reported revenue of $191.16M and net income of -$5.90M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from ULTRALIFE CORP’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Miscellaneous Electrical Machinery, Equipment & Supplies.

Income

ULTRALIFE CORP income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$191.16M$164.46M$158.64M$131.84M$98.27M$107.71M$106.80M$87.19M$85.53M$82.46M
Cost of revenue$145.14M$122.14M$119.44M$102.44M$73.62M$78.55M$75.63M$61.61M$59.30M$57.35M
Gross profit$46.02M$42.31M$39.20M$29.40M$24.64M$29.16M$31.16M$25.58M$26.23M$25.11M
Operating income-$5.90M$9.96M$9.48M$129.00K$35.00K$5.70M$7.37M$6.56M$6.48M$3.76M
Net income-$5.90M$6.31M$7.20M-$119.00K-$234.00K$5.23M$5.20M$24.93M$7.65M$3.51M
Research & development$10.40M$8.27M$7.53M$7.08M$6.83M$5.95M$6.80M$4.51M$4.74M$5.95M
Weighted-average diluted sharesshares 16.64Mshares 16.77Mshares 16.23Mshares 16.12Mshares 16.04MUnavailableshares 16.18Mshares 16.35MUnavailableshares 15.40M
Pretax income-$8.40M$8.30M$9.12M-$446.00K-$151.00K$7.02M$6.77M$6.61M$6.30M$3.58M
Income tax expense-$2.45M$1.89M$1.95M-$326.00K$79.00K$1.69M$1.46M-$18.39M-$1.37M$98.00K
Diluted EPS$-35.00$38.00$0.44$0.05$0.05$0.33$32.00$1.53$0.48$0.23
Selling, general & administrative$29.34M$24.08M$22.19M$22.19M$17.78M$17.51M$16.99M$14.52M$15.02M$15.40M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

ULTRALIFE CORP balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Cash & equivalents$9.34M$6.85M$10.20M$5.63M$8.33M$10.56M$7.14M$25.58M$18.24MUnavailable
Total assets$216.91M$220.45M$178.28M$168.43M$159.54M$137.70M$144.56M$120.85M$97.19M$84.74M
Current assets$105.80M$97.16M$90.20M$78.99M$66.52M$64.50M$70.37M$67.16M$61.92M$49.42M
Total liabilities$86.78M$86.26M$52.85M$52.03M$41.80M$20.78M$34.81M$16.38M$18.14M$16.88M
Current liabilities$37.33M$29.29M$23.73M$28.91M$18.92M$18.71M$17.19M$15.39M$14.24M$11.33M
Total equity incl. NCI$130.13M$134.19M$125.43M$116.40M$117.74M$116.92M$109.75M$104.46M$79.05M$67.86M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$54.01M$51.36M$42.22M$41.19M$33.19M$28.19M$29.76M$22.84M$26.33M$23.46M
Accounts receivable$33.95M$29.37M$31.76M$27.78M$20.23M$21.05M$30.11M$16.02M$14.66M$13.18M
Goodwill$45.38M$45.01M$37.57M$37.43M$38.07M$27.02M$26.75M$20.11M$20.46M$19.96M
Long-term debt$45.53M$51.50M$23.62M$19.31M$18.86M$0$15.78MUnavailableUnavailableUnavailable
Accounts payable$17.42M$14.16M$11.34M$16.07M$9.82M$10.84M$9.39M$9.92M$8.79M$7.29M

Cash flow

ULTRALIFE CORP cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Operating cash flow$10.99M$16.64M$1.93M-$1.26M$4.32M$21.72M-$2.97M$10.89M$7.27M$7.65M
Capital expenditures$3.87M$1.93M$2.55M$1.68M$2.81M$3.10M$6.28M$4.18M$1.39M$1.22M
Investing cash flow-$3.87M-$49.95M-$2.55M-$1.68M-$26.33M-$2.98M-$31.53M-$4.18M-$1.39M-$11.08M
Financing cash flow-$4.68M$29.86M$5.49M$518.00K$19.64M-$15.69M$16.12M$1.17M$1.40M-$175.00K
Net change in cash$2.49M-$3.42M$4.56M-$2.70M-$2.24M$3.25M-$18.53M$7.60M$7.62MUnavailable
Stock-based compensation$935.00K$698.00K$528.00K$776.00K$671.00K$943.00K$753.00K$890.00K$653.00K$710.00K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailable$0$1.96M$742.00KUnavailable$607.00K
Depreciation & amortizationUnavailableUnavailable$3.91M$4.46M$3.54M$2.94M$2.74M$2.37M$2.43M$2.73M

Derived

ULTRALIFE CORP derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Free cash flow$7.12M$14.70M-$623.00K-$2.94M$1.51M$18.62M-$9.25M$6.70M$5.88M$6.43M
Gross margin24.1%25.7%24.7%22.3%25.1%27.1%29.2%29.3%30.7%30.4%
Operating margin-3.1%6.1%6.0%0.1%0.0%5.3%6.9%7.5%7.6%4.6%
FCF margin3.7%8.9%-0.4%-2.2%1.5%17.3%-8.7%7.7%6.9%7.8%
SBC / revenue0.5%0.4%0.3%0.6%0.7%0.9%0.7%1.0%0.8%0.9%
Current ratio2.83x3.32x3.80x2.73x3.52x3.45x4.09x4.37x4.35x4.36x
Revenue YoY growth16.2%3.7%20.3%34.2%-8.8%0.9%22.5%1.9%3.7%Unavailable
Net margin-3.1%3.8%4.5%-0.1%-0.2%4.9%4.9%28.6%8.9%4.3%
R&D / revenue5.4%5.0%4.7%5.4%6.9%5.5%6.4%5.2%5.5%7.2%
CapEx / revenue2.0%1.2%1.6%1.3%2.9%2.9%5.9%4.8%1.6%1.5%
Long-term debt / equity0.35xUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailable22.8%21.4%UnavailableUnavailable24.1%21.5%-278.0%-21.7%2.7%

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ULBI in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-07View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-03-23View SEC filing
10-Q · Filed 2025-11-17View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.